LifeMD (LFMD) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on LifeMD (LFMD) is Moderate Underperform.

The composite score behind that read is -0.39, weighing +0.00 of bullish evidence against -0.38 bearish.

LifeMD last closed at $2.72, -0.73% on the session.

Against the IVW growth benchmark the position is -1.65% over the forecast window.

The read is built from 13 underlying insights — 0 bullish and 13 bearish.

Agreement across those insights is 100%.

16 graded predictions for LFMD so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks LifeMD in the 4th percentile on return on equity, where 100 is best.

LifeMD is classified under Health Care / Health Care Technology, with a market capitalisation of $132.07M.

StockMap tracks LifeMD as the 16th largest of the 18 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 12 Neutral and 6 Moderate Underperform.

On that composite LifeMD ranks 16th of 18 in the group, against a group median of -0.10.